- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 5, 2022
Discovery & Translation
Intima’s public neoantigen discovery platform; plus MS autoantigens and more
BioCentury’s roundup of translational news
Items per page:
1 - 2 of 2